Type : Contract
ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION Solicitation ID/Procurement Identifier: 75F40123P00366 Ultimate Completion Date: Tue Sep 24 17:00:00 GMT 2024
ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION Solicitation ID/Procurement Identifier: 75F40123P00366 Ultimate Completion Date: Tue Sep 24 17:00:00 GMT 2024
Active Pharmaceutical Ingredients (API) Manufacturer Data AcquisitionUS Food Drug and Administration (FDA) Center for Drug Evaluation and Research (CDER) is interested in improving and validating their understandingof the worldwide Active Pharmaceutical Ingredients (API), their manufacturing facilities and their activities, and recognizing the critical importance that API manufacturers have in producing safe and effective drugs.To that end, CDER would
API MANUFACTURER DATA Solicitation ID/Procurement Identifier: RFQ-FDA-21-1242305 Ultimate Completion Date: Sat Sep 24 17:00:00 GMT 2022
To obtain API manufacturing facility and product data that can assist CDER in programs that rely on manufacturing information for the purposes of compliance, surveillance, enforcement, drug shortages and user fee collections.See enclosed Sources Sought Notice for full detail of requirement.
Amendment No: 1See enclosed Attachement No: 2 - Questions & Answers. Issued date September 11, 2020_____________________________________________________________________________The U.S. Food and Drug Administration’s (FDA), Center for Drug Evaluation and Research (CDER), requires a contract to obtain Active Pharmaceutical Ingredients’ (API), their manufacturing facilities and their activities.Please see enclosed RFP for full details.
ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION Solicitation ID/Procurement Identifier: 75F40122P00346 Ultimate Completion Date: Sun Sep 24 17:00:00 GMT 2023
Sources Sought Only - API Manufacturec Data AcquisitionSee attached document for full description of the requirement